LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
Pending LLM rewrite. Source: FDA_DRUG D-0259-2026.
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
The recalled product
- Product
- LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Brand
- LEVOTHYROXINE SODIUM
- Manufacturer
- Alvogen, Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # MHA21825
- Exp Date: December 31
- 2027
UPCs (11)
- 0347781649906
- 0347781671907
- 0347781643904
- 0347781657901
- 0347781640903
- 0347781651909
- 0347781662905
- 0347781665906
- 0347781646905
- 0347781654900
- 0347781659905
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LEVOTHYROXINE SODIUM
- ModerateLevothyroxine Sodium 300 mcg Tablets Recalled for Subpotency
FDA (Drugs) · 2026-07-08
- HighMacleods levothyroxine 150 microgram tablets recalled as a subpotent drug
FDA (Drugs) · 2026-04-01
- HighLevothyroxine 88 microgram tablets recalled as subpotent after long term stability testing
FDA (Drugs) · 2025-10-15
- HighLevothyroxine sodium 25 microgram tablets assayed below the approved specification
FDA (Drugs) · 2025-07-23
- HighLevothyroxine sodium 112 microgram tablets assayed below the approved specification
FDA (Drugs) · 2025-07-23
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22